Literature DB >> 19182167

A salience dysregulation syndrome.

Jim van Os.   

Abstract

Revisions of DSM and ICD are forthcoming. Should the old categories of psychotic disorder, in particular the construct of schizophrenia, be retained or is a new system of representation of psychosis in order? It is argued that both scientific and societal developments point to a system of classification combining categorical and dimensional representations of psychosis in DSM and ICD. Furthermore, it is proposed to introduce, analogous to the functional descriptive term ;metabolic syndrome', the diagnosis of salience dysregulation syndrome. Within this syndrome, three sub-categories may be identified, based on scientific evidence of relatively valid and specific contrasts: with affective expression; with developmental expression; and not otherwise specified.

Entities:  

Mesh:

Year:  2009        PMID: 19182167     DOI: 10.1192/bjp.bp.108.054254

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  22 in total

1.  [Schizophrenia: more than just a "disturbance of the integrity of the self"].

Authors:  U Palm; M Lieb
Journal:  Nervenarzt       Date:  2012-03       Impact factor: 1.214

Review 2.  [Is delusion a reasonable scientific term? Reflections on psychopathology in the psychiatry of the twenty-first century].

Authors:  P Hoff
Journal:  Nervenarzt       Date:  2016-01       Impact factor: 1.214

Review 3.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

Review 4.  [Deconstructing schizophrenia. Dimensional models or division into subtypes?].

Authors:  M Jäger; K Frasch; F U Lang; T Becker
Journal:  Nervenarzt       Date:  2012-03       Impact factor: 1.214

5.  The next stage for diagnosis: validity through utility.

Authors:  Patrick D McGorry
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

6.  Renaming schizophrenia: benefits, challenges and barriers.

Authors:  Antonio Lasalvia; Mirella Ruggeri
Journal:  Epidemiol Psychiatr Sci       Date:  2018-11-26       Impact factor: 6.892

7.  The debate about renaming schizophrenia: a new name would not resolve the stigma.

Authors:  W Gaebel; A Kerst
Journal:  Epidemiol Psychiatr Sci       Date:  2018-09-11       Impact factor: 6.892

Review 8.  [Syndromal versus nosological diagnosis].

Authors:  M Jäger; K Frasch; T Becker
Journal:  Nervenarzt       Date:  2013-09       Impact factor: 1.214

9.  Subjective emotional over-arousal to neutral social scenes in paranoid schizophrenia.

Authors:  Evelina Haralanova; Svetlozar Haralanov; Anna Beraldi; Hans-Jürgen Möller; Kristina Hennig-Fast
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-27       Impact factor: 5.270

10.  Receptor mechanisms of antipsychotic drug action in bipolar disorder - focus on asenapine.

Authors:  Gavin P Reynolds
Journal:  Ther Adv Psychopharmacol       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.